BeOne Medicines (ONC) Revenue (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02% |
| Dec 31, 2025 | 6.08% |
| Sep 30, 2025 | 7.37% |
| Jun 30, 2025 | 17.72% |
| Mar 31, 2025 | -0.93% |
| Dec 31, 2024 | 12.60% |
| Sep 30, 2024 | 7.80% |
| Jun 30, 2024 | 23.62% |
| Mar 31, 2024 | 18.48% |
| Dec 31, 2023 | -18.80% |
| Sep 30, 2023 | 31.25% |
| Jun 30, 2023 | 32.93% |
| Mar 31, 2023 | 17.81% |
| Dec 31, 2022 | -1.94% |
| Sep 30, 2022 | 13.48% |
| Jun 30, 2022 | 11.40% |
| Mar 31, 2022 | 43.30% |
| Dec 31, 2021 | 3.65% |
| Sep 30, 2021 | 37.63% |
| Jun 30, 2021 | -75.24% |
| Mar 31, 2021 | 505.27% |
| Dec 31, 2020 | 9.90% |
| Sep 30, 2020 | 38.77% |
| Jun 30, 2020 | 26.08% |
| Mar 31, 2020 | -8.50% |
| Dec 31, 2019 | 13.46% |
| Sep 30, 2019 | -66.57% |
| Jun 30, 2019 | 92.72% |
| Mar 31, 2019 | 32.66% |
| Dec 31, 2018 | 8.24% |
| Sep 30, 2018 | 2.65% |
| Jun 30, 2018 | 62.25% |
| Mar 31, 2018 | 79.07% |
| Dec 31, 2017 | -91.75% |
| Jun 30, 2016 | -41.95% |
| Mar 31, 2016 | -85.52% |
| Dec 31, 2015 | 238.91% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | 0.07% |